I. Clinical Aspects and Investigations
- 1 June 1961
- journal article
- editorial
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 34 (402) , 337-346
- https://doi.org/10.1259/0007-1285-34-402-337
Abstract
The use of radioactive yttrium (90Y) is reviewed as an alternative to 198Au for malignant effusions. Fifteen cases were treated by intracavitary injection of a new compound, colloidal yttrium silicate. Of nine patients surviving longer than one month, six received good palliation for periods ranging from five to 19 months. The intracavitary retention and extracavitary dosage are detailed and compared with those of other yttrium preparations and with gold.Keywords
This publication has 11 references indexed in Scilit:
- DIRECT INSTILLATION OF NITROGEN MUSTARD IN THE MANAGEMENT OF MALIGNANT EFFUSIONSAnnals of the New York Academy of Sciences, 1958
- Metabolism of the Lanthanons in the Rat.Experimental Biology and Medicine, 1956
- Distribution of Colloidal Radioactive Chromic Phosphate after Intracavitary AdministrationRadiology, 1954
- THE PREVENTION OF PERITONEAL TUMOR IMPLANTS BY RADIOACTIVE COLLOIDAL GOLD (Au19S)Annals of Surgery, 1954
- Metabolism of radioyttriumArchives of Biochemistry and Biophysics, 1953
- Metabolism and distribution of colloidal Au198 injected into serous cavities for treatment of effusions associated with malignant neoplasmsCancer, 1953
- THE DEPOSITION OF Y-91 IN RABBIT BONES1953
- Biological Studies on Stable and Radioactive Rare Earth Compounds. I. On the Distribution of Lanthanum in the Mammalian Organism2JNCI Journal of the National Cancer Institute, 1952
- THE SKELETAL DESPOSITION OF YTTRIUMPublished by Elsevier ,1952
- THE SKELETAL DEPOSITION OF YTTRIUM1952